Your browser's JavaScript is disabled.

To properly view the content on this page, please enable JavaScript.

Publications

Clinical Imetelstat: MDS

All Publications

IMerge: A Phase 3 Study to Evaluate Imetelstat in Transfusion-Dependent Subjects with IPSS Low or Intermediate-1 Risk Myelodysplastic Syndromes (MDS) that is Relapsed/Refractory to Erythropoiesis-Stimulating Agent (ESA) Treatment

Clinical Imetelstat: MDS Imetelstat

Platzbecker, et al.

Treatment with Imetelstat Provides Durable Transfusion Independence (TI) in Heavily Transfused Non-Del(5Q) Lower Risk MDS (LR-MDS) Relapsed/Refractory (R/R) to Erythropoiesis Stimulating Agents (ESAs)

Clinical Imetelstat: MDS Imetelstat

Platzbecker, et al.

IMerge: A Study to Evaluate Imetelstat (GRN163L) in Transfusion-Dependent Subjects with IPSS Low or Intermediate-1 Risk Myelodysplastic Syndromes (MDS) that is Relapsed/Refractory to Erythropoiesis-Stimulating Agent (ESA) Treatment

Clinical Imetelstat: MDS Imetelstat

Platzbecker, et al.

Treatment with Imetelstat Provides Durable Transfusion Independence in Heavily Transfused Non-del(5q) Lower Risk MDS Relapsed/Refractory to Erythropoiesis-Stimulating Agents

Clinical Imetelstat: MDS Imetelstat

Fenaux, P, et al.

Imetelstat Treatment Leads to Durable Transfusion Independence in RBC Transfusion-Dependent, Non-Del(5q) Lower Risk MDS Relapsed/Refractory to Erythropoiesis-Stimulating Agent Who Are Lenalidomide and HMA Naive

Clinical Imetelstat: MDS Imetelstat

Steemsma D, et al.

Imetelstat in RBC Transfusion-Dependent Lower Risk MDS Relapsed/Refractory to Erythropoiesis-Stimulating Agents (IMerge): Updated Efficacy and Safety

Clinical Imetelstat: MDS Imetelstat

Fenaux P, et al.

Efficacy and Safety of Imetelstat in RBC Transfusion-Dependent (TD) IPSS Low/Int-1 MDS Relapsed/Refractory to Erythropoiesis-Stimulating Agents (ESA) (IMerge)

Clinical Imetelstat: MDS Imetelstat

Fenaux P, et al.

Imetelstat Therapy in Refractory Anemia with Ring Sideroblasts with or without Thrombocytosis

Clinical Imetelstat: MDS Imetelstat

Blood Cancer Journal 2016

Tefferi A, et al.

Telomerase Inhibitor Imetelstat Therapy in Refractory Anemia with Ring Sideroblasts with or without Thrombocytosis

Clinical Imetelstat: MDS Imetelstat

Tefferi A, et al.

[facetwp facet="publication_load_more"]